CHM
Click for more information
0.00% 1.8¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-12

  1. Steini
    12,278 Posts.
    lightbulb Created with Sketch. 3754
    clock Created with Sketch.
    09/02/24
    12:21
    Post #: 72323073
    ALA's EV now 25-30x that of CHM having not one clinical trial running and hardly any $ left. If they got valued correctly, CHM's and especially IMU's MC should be in the billions. The strange ASX valuations are continuing.

    GLTA
    CHM Price at posting: 2.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.52M
Open High Low Value Volume
1.9¢ 2.0¢ 1.8¢ $9.097K 486.9K

Buyers (Bids)

No. Vol. Price($)
2 134207 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 99000 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.